Impact of early intensive reinduction therapy on event-free survival in children with low-risk acute lymphoblastic leukemia

Haematol Blood Transfus. 1990:33:483-8. doi: 10.1007/978-3-642-74643-7_87.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / administration & dosage
  • Child
  • Cyclophosphamide / administration & dosage
  • Daunorubicin / administration & dosage
  • Dexamethasone / administration & dosage
  • Doxorubicin / administration & dosage
  • Germany, West / epidemiology
  • Humans
  • Leucovorin / administration & dosage
  • Life Tables
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Multicenter Studies as Topic
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Prednisolone / administration & dosage
  • Randomized Controlled Trials as Topic
  • Risk
  • Survival Rate
  • Thioguanine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Prednisolone
  • Mercaptopurine
  • Asparaginase
  • Thioguanine
  • Leucovorin
  • Methotrexate
  • Daunorubicin